An investigation on behalf of investors of Allergan plc (NASDAQ: AGN) in connection with the proposed takeover was announced and Allergan plc (NASDAQ: AGN stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 08/02/2019 -- An investigation was announced for investors, who currently hold shares of Allergan plc (NASDAQ: AGN), concerning whether the takeover of Allergan plc is unfair to NASDAQ: AGN stockholders.
Investors who purchased shares of Allergan plc (NASDAQ: AGN) and currently hold any of those NASDAQ: AGN shares have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain officers and directors of Allergan plc breached their fiduciary duties owed to NASDAQ: AGN investors in connection with the proposed acquisition.
On June 25, 2019, AbbVie Inc. and Allergan announced that the companies have entered into a transaction agreement under which AbbVie will acquire Allergan in a cash and stock transaction for a transaction equity value of approximately $63 billion, based on the closing price of AbbVie's common stock of $78.45 on June 24, 2019. Allergan Shareholders will receive 0.8660 AbbVie Shares and $120.30 in cash for each Allergan Share that they hold.
However, given that at least one analyst has set the high target price for NASDAQ: AGN shares at $255.00 per share, the investigation concerns whether the offer is unfair to NASDAQ: AGN stockholders. More specifically, the investigation concerns whether the Allergan Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.
On August 1, 2019, NASDAQ: AGN shares closed at $160.91 per share.
Those who are current investors in Allergan plc (NASDAQ: AGN) shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels